
Toronto Real Estate Prices Climb As Inventory Remains Near Highs
Key Takeaways
- •Prices rose 0.3% to $941.8k CAD ($697k USD)
- •Annual price growth fell 7.4% YoY, still negative
- •Sales increased 1.7% but remain among weakest Marches
- •Active listings at 21,596, supply outpaces demand
- •Sales‑to‑new‑listings ratio 34.9% signals buyer’s market
Pulse Analysis
Toronto’s modest price uptick in March reflects a market that is still grappling with lingering oversupply. While the composite benchmark climbed to CAD 941,800 (about $697,000 USD), the 0.3% gain is far below the rapid appreciation seen during the 2021‑2022 boom. Compared with the peak of over $1.1 million CAD in mid‑2022, the current level signals a cooling cycle, driven partly by tighter mortgage financing and higher borrowing costs that have dampened buyer enthusiasm.
Inventory dynamics are the primary headwind. With 21,596 homes on the market—still among the highest March figures in the past quarter‑century—supply outstrips demand, producing a sales‑to‑new‑listings ratio of just 34.9%. This ratio traditionally flags a buyer’s market, where sellers may need to lower prices or offer concessions to attract limited buyer traffic. The modest 1.7% rise in sales volume masks a downward revision of last year’s figures, highlighting that the market’s underlying momentum remains weak despite a slight seasonal bump.
Looking ahead, the spring season will test whether demand can absorb the surplus. Unless there is a significant shift in buyer sentiment—perhaps spurred by a stabilization of interest rates or a correction in new‑construction pricing—price growth is likely to stay tepid. Developers and investors should monitor the inventory backlog and the evolving affordability landscape, as prolonged excess could pressure resale values and delay new project launches. In this context, Toronto’s real‑estate outlook hinges on a delicate balance between supply reduction and renewed buyer confidence.
Toronto Real Estate Prices Climb As Inventory Remains Near Highs
Comments
Want to join the conversation?